The Otubain YOD1 Suppresses Aggregation and Activation of the Signaling Adaptor MAVS through Lys63-Linked Deubiquitination

Chang Liu,Shan Huang,Xuelin Wang,Mingjie Wen,Jiarui Zheng,Wenjuan Wang,Yanbin Fu,Shunli Tian,Long Li,Zexing Li,Xi Wang
DOI: https://doi.org/10.4049/jimmunol.1800656
2019-04-05
The Journal of Immunology
Abstract:Key points<p><li><p>The otubain YOD1 fine-tunes MAVS-RLR pathway–mediated antiviral immunity.</p></li><li><p>YOD1 interacts with MAVS on mitochondria.</p></li><li><p>YOD1 deubiquitinates MAVS and abrogates aggregation of MAVS.</p></li></p>
What problem does this paper attempt to address?